Saidi, A. N. https://orcid.org/0009-0003-9732-430X
Burggraaf, B. https://orcid.org/0000-0002-3935-1233
van der Lelij, A. J. https://orcid.org/0000-0002-1059-0126
van der Zwan-van Beek, E. https://orcid.org/0009-0004-3464-264X
Cabezas, M. Castro https://orcid.org/0009-0009-5164-2082
Article History
Received: 19 May 2026
Accepted: 9 July 2026
First Online: 24 July 2026
Declarations
Conflict of interest: The authors declare they have no conflicts of interest.
Ethics approval: Ethics approval and consent to participate This study involves human participants, and the original study (FRANCIS) was approved by the medical ethical committee of the Maasstad hospital in Rotterdam, the Netherlands (The Dutch Trial register, NTR3873; ABR no. NL32669.101.10) and was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonisation Guidance for Good Clinical Practice. Written informed consent was obtained from all participants in the original FRANCIS trial before enrolment.
Consent for publication: Not applicable.
Disclosures: No part of this manuscript has been copied, published elsewhere, or submitted simultaneously for publication.
Conference presentation: No part of this work has been previously presented at a conference or published as a congress abstract.
AI use disclosure: No artificial intelligence tools were used in the drafting or editing of this manuscript.